117 related articles for article (PubMed ID: 30738963)
1. Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.
Ferri C; Weich N; Gutiérrez L; De Brasi C; Bengió MR; Zapata P; Fundia A; Larripa I
Gene; 2019 Apr; 694():71-75. PubMed ID: 30738963
[TBL] [Abstract][Full Text] [Related]
2. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy.
Ferri C; Bianchini M; Bengió R; Larripa I
Blood Cells Mol Dis; 2014; 52(2-3):121-5. PubMed ID: 24091144
[TBL] [Abstract][Full Text] [Related]
3. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice.
Peng C; Chen Y; Yang Z; Zhang H; Osterby L; Rosmarin AG; Li S
Blood; 2010 Jan; 115(3):626-35. PubMed ID: 19965668
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia.
Kim DH; Xu W; Ma C; Liu X; Siminovitch K; Messner HA; Lipton JH
Blood; 2009 Mar; 113(11):2517-25. PubMed ID: 19141860
[TBL] [Abstract][Full Text] [Related]
5. Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia.
Morotti A; Torti D; Carra G; Panuzzo C; Crivellaro S; Taulli R; Fava C; Guerrasio A; Saglio G
Curr Drug Targets; 2017; 18(4):389-395. PubMed ID: 27291926
[TBL] [Abstract][Full Text] [Related]
6. TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa I; Fundia A
Blood Cells Mol Dis; 2016 Jul; 59():129-33. PubMed ID: 27282582
[TBL] [Abstract][Full Text] [Related]
7. Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.
Woo YM; Kim S; Park JH; Lee NY; Kim JW; Kim DDH
PLoS One; 2019; 14(6):e0218968. PubMed ID: 31237926
[TBL] [Abstract][Full Text] [Related]
8. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
[TBL] [Abstract][Full Text] [Related]
9. HAUSP compartmentalization in chronic myeloid leukemia.
Morotti A; Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G
Eur J Haematol; 2015 Apr; 94(4):318-21. PubMed ID: 25082234
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts.
Huet S; Dulucq S; Chauveau A; Ménard A; Chomel JC; Maisonneuve H; Legros L; Perrin MC; Ferrant E; Moreilhon C; Couturier MA; Sujobert P; Magaud JP; Ugo V; Chabane K; Raynaud S; Hayette S;
Genes Chromosomes Cancer; 2015 Oct; 54(10):595-605. PubMed ID: 26252834
[TBL] [Abstract][Full Text] [Related]
11. The rs61764370 Functional Variant in the KRAS Oncogene is Associated with Chronic Myeloid Leukemia Risk in Women.
Gutiérrez-Malacatt H; Ayala-Sanchez M; Aquino-Ortega X; Dominguez-Rodriguez J; Martinez-Tovar A; Olarte-Carrillo I; Martinez-Hernandez A; C CC; Orozco L; Cordova EJ
Asian Pac J Cancer Prev; 2016; 17(4):2265-70. PubMed ID: 27221928
[TBL] [Abstract][Full Text] [Related]
12. [Variation of LNK Gene in Chronic Myeloid Leukemia].
Tan M; Rong Y; Tian RM; Zhu YH; Zhu P; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):706-710. PubMed ID: 28641622
[TBL] [Abstract][Full Text] [Related]
13. [A clinical and laboratory study of chronic myeloid leukemia with atypical BCR-ABL fusion gene subtypes].
Gui X; Pan J; Qiu H; Cen J; Xue Y; Chen S; Shen H; Yao L; Zhang J; Wu Y; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):210-4. PubMed ID: 24666486
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic, fluorescence in situ hybridization, and genomic array characterization of chronic myeloid leukemia with cryptic BCR-ABL1 fusions.
Shao L; Miller S; Keller-Ramey J; Zhang Y; Roulston D
Cancer Genet; 2015; 208(7-8):396-403. PubMed ID: 26186983
[TBL] [Abstract][Full Text] [Related]
16. Chronic Myeloid Leukemia (CML) Mouse Model in Translational Research.
Peng C; Li S
Methods Mol Biol; 2016; 1438():225-43. PubMed ID: 27150093
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
Panuzzo C; Crivellaro S; Carrà G; Guerrasio A; Saglio G; Morotti A
PLoS One; 2014; 9(10):e110682. PubMed ID: 25343485
[TBL] [Abstract][Full Text] [Related]
18. High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.
Xie J; Wang Q; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Cancer Genet; 2014 May; 207(5):226-30. PubMed ID: 24998463
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia.
Soverini S; de Benedittis C; Mancini M; Martinelli G
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S120-8. PubMed ID: 26297264
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
